- Home
- RVPH vs IVCA Comparison
RVPH vs IVCA Comparison
Compare RVPH & IVCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- IVCA
- Stock Information
- Founded
- RVPH 2006
- IVCA 2021
- Country
- RVPH United States
- IVCA Cayman Islands
- Employees
- RVPH N/A
- IVCA N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- IVCA Blank Checks
- Sector
- RVPH Health Care
- IVCA Finance
- Exchange
- RVPH Nasdaq
- IVCA Nasdaq
- Market Cap
- RVPH 87.6M
- IVCA 93.8M
- IPO Year
- RVPH N/A
- IVCA 2022
- Fundamental
- Price
- RVPH $1.92
- IVCA $11.85
- Analyst Decision
- RVPH Strong Buy
- IVCA
- Analyst Count
- RVPH 5
- IVCA 0
- Target Price
- RVPH $11.40
- IVCA N/A
- AVG Volume (30 Days)
- RVPH 3.0M
- IVCA 713.0
- Earning Date
- RVPH 11-14-2024
- IVCA 01-01-0001
- Dividend Yield
- RVPH N/A
- IVCA N/A
- EPS Growth
- RVPH N/A
- IVCA N/A
- EPS
- RVPH N/A
- IVCA 0.26
- Revenue
- RVPH N/A
- IVCA N/A
- Revenue This Year
- RVPH N/A
- IVCA N/A
- Revenue Next Year
- RVPH N/A
- IVCA N/A
- P/E Ratio
- RVPH N/A
- IVCA $45.99
- Revenue Growth
- RVPH N/A
- IVCA N/A
- 52 Week Low
- RVPH $0.60
- IVCA $11.07
- 52 Week High
- RVPH $4.83
- IVCA $12.37
- Technical
- Relative Strength Index (RSI)
- RVPH 52.37
- IVCA 54.79
- Support Level
- RVPH $1.56
- IVCA $11.76
- Resistance Level
- RVPH $2.06
- IVCA $12.03
- Average True Range (ATR)
- RVPH 0.23
- IVCA 0.05
- MACD
- RVPH -0.01
- IVCA -0.00
- Stochastic Oscillator
- RVPH 52.46
- IVCA 33.33
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About IVCA Investcorp India Acquisition Corp.
Investcorp AI Acquisition Corp is a blank check company.